CARUSO JAMES V

CIK 00012027703 companiesFLORHAM PARK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001202770

Recent Transactions

50 trades

Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2026-07-07+250,000→ 250,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Warrants
2026-05-07$0.01/sh+26,040→ 36,076 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2026-05-07$2.88/sh+8,680→ 20,318 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2025-07-02$4.99/sh+10,000→ 11,638 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Warrants
2025-07-02$0.01/sh+10,000→ 10,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2025-02-14+900,000→ 900,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2024-06-14+900,000→ 900,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Common Stock
2023-12-08+40,596→ 49,236 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2023-06-23+261,000→ 261,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2023-01-17+261,000→ 261,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2022-01-25+1,419,000→ 1,419,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2021-03-04$1.70/sh+5,100→ 86,401 total
Sale
Cellectar Biosciences, Inc.$CLRB
Series A Warrants
2021-03-04$0.19/sh+46,948→ 0 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2021-03-04+1,600,000→ 1,600,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2020-12-28$1.35/sh+37,037→ 81,301 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Series H Warrants
2020-06-05$0.01/sh+10,870→ 10,870 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2020-06-05$1.15/sh+21,740→ 44,264 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2020-02-03+100,000→ 100,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Common stock
2020-02-03$2.71/sh+100,000→ 100,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2019-01-17+75,000→ 75,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2018-11-30$2.28/sh+1,000→ 22,354 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2018-10-12+150,000→ 150,000 total
Sale
Cellectar Biosciences, Inc.$CLRB
Common Stock
2018-03-12$1.20/sh−34,000→ 213,548 total
Award
Cellectar Biosciences, Inc.$CLRB
Common stock
2017-04-18+200,000→ 247,548 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2016-05-12$0.01/sh+200,000→ 237,500 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Series A Warrants
2016-04-20$0.01/sh+46,948→ 46,948 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2016-04-20$2.12/sh+46,948→ 47,548 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2015-11-24$1.30/sh+1,000→ 6,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2015-11-20$1.16/sh+1,000→ 5,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2015-11-19$1.50/sh+2,000→ 4,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2015-11-18$1.39/sh+2,000→ 2,000 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Stock Options (Right to Buy)
2010-03-01−40,000→ 60,000 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Common Stock
2010-03-01$3.13/sh+40,000→ 181,159 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2010-03-01$8.13/sh−40,000→ 141,159 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2010-03-01$8.13/sh−37,500→ 103,659 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2010-02-23$7.44/sh−5,968→ 141,159 total
Award
ALLOS THERAPEUTICS INC
Stock Options (Right to Buy)
2010-02-22$7.56/sh+102,300→ 102,300 total
Award
ALLOS THERAPEUTICS INC
Common Stock
2010-02-22+58,254→ 147,127 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2009-08-10$8.13/sh−85,400→ 88,873 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Common Stock
2009-08-10$3.13/sh+85,400→ 174,273 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Stock Options (Right to Buy)
2009-08-10−85,400→ 100,000 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Common Stock
2009-08-05$3.13/sh+14,600→ 103,473 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2009-08-05$8.13/sh−14,600→ 88,873 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Stock Options (Right to Buy)
2009-08-05−14,600→ 185,400 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Common Stock
2009-08-03$3.13/sh+50,000→ 138,873 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2009-08-03$7.79/sh−50,000→ 88,873 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Stock Options (Right to Buy)
2009-08-03−50,000→ 200,000 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2009-06-16$8.16/sh−13,500→ 88,873 total
Sale
ALLOS THERAPEUTICS INC
Common Stock
2009-06-15$8.13/sh−14,000→ 102,373 total
Exercise/Conversion
ALLOS THERAPEUTICS INC
Common Stock
2009-03-26$3.13/sh+39,500→ 155,873 total

Companies

Recent Filings

Address

C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE

FLORHAM PARK, NJ, 07932

View on SEC.gov